Synonyms: Cytosar® | DepoCyte® | U-19920
cytarabine is an approved drug (FDA (1969), EMA (2001))
Compound class:
Synthetic organic
Comment: Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1969), EMA (2001)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name |
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
International Nonproprietary Names | |
INN number | INN |
1709 | cytarabine |
Synonyms |
Cytosar® | DepoCyte® | U-19920 |
Database Links | |
CAS Registry No. | 147-94-4 (source: Scifinder) |
ChEMBL Ligand | CHEMBL803 |
DrugBank Ligand | DB00987 |
DrugCentral Ligand | 770 |
GtoPdb PubChem SID | 178101529 |
PubChem CID | 6253 |
RCSB PDB Ligand | AR3 |
Search Google for chemical match using the InChIKey | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
Search Google for chemicals with the same backbone | UHDGCWIWMRVCDJ |
Search PubMed clinical trials | cytarabine |
Search PubMed titles | cytarabine |
Search PubMed titles/abstracts | cytarabine |
UniChem Compound Search for chemical match using the InChIKey | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
Wikipedia | Cytarabine |